Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RTB101
RTB101
ResTORbio stops testing lead drug for respiratory illness; shares crash
Reuters
Fri, 11/15/19 - 11:07 am
ResTORbio
clinical trials
RTB101
Nearing phase 3, resTORbio posts new data on infection drug
Fierce Biotech
Tue, 10/16/18 - 09:46 am
ResTORbio
RTB101
respiratory infections
UTIs
Months after IPO, Novartis spinout resTORbio wins on PhIIb data — stock soars
Endpoints
Wed, 07/25/18 - 10:24 am
ResTORbio
RTB101
Novartis
Anti-aging startup ResTORbio gets $40M to fuel Phase IIb study
Endpoints
Thu, 11/30/17 - 11:03 am
anti-aging
clinical trials
ResTORbio
Novartis
RTB101